日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Organ Donation After Oral Ingestion of a Voluntary Assisted Dying Substance

口服自愿安乐死物质后进行器官捐献

Kantianis, Joanne; Opdam, Helen I; D'Costa, Rohit L

Minimum Intervention Oral Care (MIOC) - Overcoming Implementation Barriers: An International Expert Consensus

最小干预口腔护理(MIOC)——克服实施障碍:国际专家共识

Schwendicke, Falk; Banerjee, Avijit; Baker, Sarah R; Büttner, Martha; Ceballos, Laura; Cenci, Maximiliano S; Doméjean, Sophie; Fontana, Margherita; Gurgan, Sevil; Opdam, Niek J M; Perić, Tamara; Santamaría, Ruth M; Scotti, Nicola; Tenuta, Livia M A; Turkun, Lezize Sebnem; Miletić, Ivana

Efficacy of Zenocutuzumab in NRG1 Fusion-Positive Cancer

Zenocutuzumab治疗NRG1融合阳性癌症的疗效

Schram, Alison M; Goto, Koichi; Kim, Dong-Wan; Macarulla, Teresa; Hollebecque, Antoine; O'Reilly, Eileen M; Ou, Sai-Hong Ignatius; Rodon, Jordi; Rha, Sun Young; Nishino, Kazumi; Duruisseaux, Michaël; Park, Joon Oh; Neuzillet, Cindy; Liu, Stephen V; Weinberg, Benjamin A; Cleary, James M; Calvo, Emiliano; Umemoto, Kumiko; Nagasaka, Misako; Springfeld, Christoph; Bekaii-Saab, Tanios; O'Kane, Grainne M; Opdam, Frans; Reiss, Kim A; Joe, Andrew K; Wasserman, Ernesto; Stalbovskaya, Viktoriya; Ford, Jim; Adeyemi, Shola; Jain, Lokesh; Jauhari, Shekeab; Drilon, Alexander

HER2-Selective Tyrosine Kinase Inhibitor, Zongertinib (BI 1810631), in Patients With Advanced/Metastatic Solid Tumors With HER2 Alterations: A Phase Ia Dose-Escalation Study

HER2选择性酪氨酸激酶抑制剂Zongertinib(BI 1810631)治疗HER2改变的晚期/转移性实体瘤患者:一项Ia期剂量递增研究

Heymach, John V; Opdam, Frans; Barve, Minal; Tu, Hai-Yan; Wu, Yi-Long; Berz, David; Schröter, Lukas; Botilde, Yanick; Sadrolhefazi, Behbood; Serra, Josep; Yoh, Kiyotaka; Yamamoto, Noboru

First-in-human phase 1 study of the ICOS agonist feladilimab on patients with advanced solid tumors

ICOS激动剂feladilimab治疗晚期实体瘤患者的首次人体I期研究

Maio, Michele; Moreno, Victor; Martin-Liberal, Juan; Opdam, Frans; Hansen, Aaron; Bauer, Todd M; Le Tourneau, Christophe; Italiano, Antoine; Rischin, Danny; Ellis, Catherine; Turner, David; Yadavilli, Sapna; Zhou, Helen; Hirschfeld, Steven; Ballas, Marc; Diaz-Padilla, Ivan; Angevin, Eric

When the hospital becomes an option again: a qualitative analysis of women's and their partners' experiences with a designated clinic for women who request different care than recommended in the guidelines

当医院再次成为一种选择时:对寻求与指南建议不同的护理的女性及其伴侣在指定诊所的经历进行定性分析

Dimmendaal, Marene; Opdam, Floor; van Dillen, Jeroen; de Vries, Marieke; Hollander, Martine

Pharmacokinetic boosting of olaparib: Study protocol of a multicentre, open-label, randomised, non-inferiority trial (PROACTIVE-B)

奥拉帕尼药代动力学增强:一项多中心、开放标签、随机、非劣效性试验的研究方案(PROACTIVE-B)

Overbeek, Joanneke K; Guchelaar, Niels A D; Mohmaed Ali, Ma Ida; Sark, Muriëlle; Hovenier, Carolien; Kievit, Wietske; Ligtenberg, Marjolijn J L; Ottevanger, Petronella B; Bloemendal, Haiko J; Koolen, Stijn L W; Mathijssen, Ron H J; Boere, Ingrid A; Huitema, Alwin D R; Sonke, Gabe S; Opdam, Frans L; Ter Heine, Rob; van Erp, Nielka P

Inference-Based Cognitive Behavioral Therapy versus Cognitive Behavioral Therapy for Obsessive-Compulsive Disorder: A Multisite Randomized Controlled Non-Inferiority Trial

基于推理的认知行为疗法与认知行为疗法治疗强迫症的比较:一项多中心随机对照非劣效性试验

Wolf, Nadja; van Oppen, Patricia; Hoogendoorn, Adriaan W; van den Heuvel, Odile A; van Megen, Harold J G M; Broekhuizen, Aniek; Kampman, Mirjam; Cath, Daniëlle C; Schruers, Koen R J; van Es, Saskia M; Opdam, Tamara; van Balkom, Anton J L M; Visser, Henny A D

Long-term outcomes of young, node-negative, chemotherapy-naïve, triple-negative breast cancer patients according to BRCA1 status

根据 BRCA1 状态评估年轻、淋巴结阴性、未接受化疗的三阴性乳腺癌患者的长期预后

Wang, Yuwei; Dackus, Gwen M H E; Rosenberg, Efraim H; Cornelissen, Sten; de Boo, Leonora W; Broeks, Annegien; Brugman, Wim; Chan, Terry W S; van Diest, Paul J; Hauptmann, Michael; Ter Hoeve, Natalie D; Isaeva, Olga I; de Jong, Vincent M T; Jóźwiak, Katarzyna; Kluin, Roelof J C; Kok, Marleen; Koop, Esther; Nederlof, Petra M; Opdam, Mark; Schouten, Philip C; Siesling, Sabine; van Steenis, Charlaine; Voogd, Adri C; Vreuls, Willem; Salgado, Roberto F; Linn, Sabine C; Schmidt, Marjanka K

Prognostic value of histopathologic traits independent of stromal tumor-infiltrating lymphocyte levels in chemotherapy-naïve patients with triple-negative breast cancer

组织病理学特征在未经化疗的三阴性乳腺癌患者中具有独立于间质肿瘤浸润淋巴细胞水平的预后价值

de Boo, L W; Jóźwiak, K; Ter Hoeve, N D; van Diest, P J; Opdam, M; Wang, Y; Schmidt, M K; de Jong, V; Kleiterp, S; Cornelissen, S; Baars, D; Koornstra, R H T; Kerver, E D; van Dalen, T; Bins, A D; Beeker, A; van den Heiligenberg, S M; de Jong, P C; Bakker, S D; Rietbroek, R C; Konings, I R; Blankenburgh, R; Bijlsma, R M; Imholz, A L T; Stathonikos, N; Vreuls, W; Sanders, J; Rosenberg, E H; Koop, E A; Varga, Z; van Deurzen, C H M; Mooyaart, A L; Córdoba, A; Groen, E; Bart, J; Willems, S M; Zolota, V; Wesseling, J; Sapino, A; Chmielik, E; Ryska, A; Broeks, A; Voogd, A C; van der Wall, E; Siesling, S; Salgado, R; Dackus, G M H E; Hauptmann, M; Kok, M; Linn, S C